Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:10:25.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; the v3.4.3 entry has been removed.
    Difference
    0.0%
    Check dated 2026-03-25T20:35:20.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:21:20.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added to the page. The lapse-in-funding notice and the Revision: v3.4.1 entry have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:49:44.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A government funding notice was added noting potential processing delays and that the NIH Clinical Center is open, and the page was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T22:57:48.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a 'Show glossary' control and updated QC-related labels to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-27T16:59:19.000Z thumbnail image

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.